STAT+: Indonesian ruling against ‘patent evergreening’ by pharma industry sends critical message, patient advocates say
A recent court decision in Indonesia sends an important message to other countries to challenge the pharma industry's use of "patent evergreening," patient advocates say.
This item is an automated import from an external feed and has not yet been rewritten into a neutral C-IT-ALL summary. Read the full story at the original source below.
Read the full story at STAT News
Related Coverage